FIP Position Paper on Qualification of Paddle and Basket Dissolution Apparatus

被引:2
作者
Brown, Cynthia K. [1 ]
Buhse, Lucinda [2 ]
Friedel, Horst-Dieter
Keitel, Susanne
Kraemer, Johannes
Morris, J. Michael
Stickelmeyer, Mary [1 ]
Yomota, Chikako
Shah, Vinod P. [3 ]
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] US FDA, CDER, OPS, St Louis, MO USA
[3] FIP Sci Secretary, The Hague, Netherlands
来源
DISSOLUTION TECHNOLOGIES | 2009年 / 16卷 / 04期
关键词
D O I
10.14227/DT160409P6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The qualification process for ensuring that a paddle or basket apparatus is suitable for its intended use is a highly debated and controversial topic. Different instrument qualification and suitability methods have been proposed by the pharmacopeias and regulatory bodies. In an effort to internationally harmonize dissolution apparatus suitability requirements, the International Pharmaceutical Federation's (FIP) Dissolution/Drug Release Special Interest Group (SIG) reviewed current instrument suitability requirements listed in the United States, European, and Japanese pharmacopeias and the International Conference on Harmonization (ICH) Topic Q4B on harmonization of pharmacopoeial methods in its Annex 7, Dissolution Test General. In addition, the SIG reviewed the Food and Drug Administration (FDA) Draft Guidance for Industry, "The Use of Mechanical Calibration of Dissolution Apparatus 1 and 2-Current Good Manufacturing Practice (CGMP)" and the related ASTM Standard E2503-07. Based on this review and several in-depth discussions, the FIP Dissolution/Drug Release SIG recommends that the qualification of a dissolution test instrument should be performed following the calibration requirements as indicated in the FDA (draft) guidance. If additional system performance information is desired, a performance verification test using U.S. Pharmacopeia Reference Standard tablets or an established in-house reference product can be conducted. Any strict requirement on the use of a specific performance verification test tablet is not recommended at this time.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 10 条
  • [1] [Anonymous], 2008, EUR PHARM
  • [2] ASTM International, 2007, E250307 ASTM INT
  • [3] Perturbation study of dissolution apparatus variables - A design of experiment approach
    Eaton, Joseph
    Deng, Gang
    Hauck, Walter W.
    Brown, William
    Manning, Ronald G.
    Wahab, Samir
    [J]. DISSOLUTION TECHNOLOGIES, 2007, 14 (01): : 20 - 26
  • [4] Gao Z, 2007, AAPS PHARMSCITECH, V8
  • [5] *INT C HARM, 2008, DISS TEST GEN CHAPT
  • [6] Ministry of Health Labour and Welfare, 2006, JAP PHARM
  • [7] *SUBC DISS CAL PHR, 2000, PHARMACOPEIAL FORUM, V26, P1149
  • [8] *US DEP HHS, 2007, US MECH CAL DISS APP
  • [9] *US PHARM CONV INC, 2008, US PHARM NAT FORM SP
  • [10] 1997, DISSOLUTION TECHNOL, V4, P5